Celecoxib Japan Observational Study for the Patients With Acute Pain

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01876121

Enrollment

784

Registered

2013-06-12

Start date

2012-07-31

Completion date

2013-04-30

Last updated

2014-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain

Keywords

NSAIDs, Acute pain

Brief summary

This study is to assess the safety and efficacy of celecoxib on the pain relief from acute pain.

Detailed description

Patients with traumatic pain, post-surgical and tooth extract pain will be included in this study. Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the safety will be evaluated.

Interventions

DRUGCelecoxib

oral

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with traumatic pain, post-surgical pain and tooth extract pain

Exclusion criteria

* Hyperreactive to sulfonamide * Aspirin asthma patients * Peptidic ulcer patients * Serious liver disease patients * Serious kidney disease patients * Serious heart failure patients * End of pregnancy

Design outcomes

Primary

Measure	Time frame
Safety assessed by the incidence of adverse events and lab-tests	For 2 weeks

Secondary

Measure	Time frame
Overall pain improvement assessed by visual analogue scale (VAS)	Baseline and week-2

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026